LENZ Therapeutics News

LENZ Therapeutics Price Target Maintained With a $36.00/Share by Piper Sandler

Dow JonesAug 15 14:10 ET

BofA Securities Maintains LENZ Therapeutics(LENZ.US) With Buy Rating, Maintains Target Price $31

Moomoo NewsAug 15 09:31 ET

Piper Sandler Maintains LENZ Therapeutics(LENZ.US) With Buy Rating, Maintains Target Price $36

Moomoo NewsAug 15 07:34 ET

LENZ Therapeutics Analyst Ratings

BenzingaAug 15 06:52 ET

H.C. Wainwright Maintains LENZ Therapeutics(LENZ.US) With Buy Rating, Maintains Target Price $38

Moomoo NewsAug 15 06:31 ET

BofA Securities Initiates LENZ Therapeutics(LENZ.US) With Buy Rating, Announces Target Price $31

Moomoo NewsAug 15 05:31 ET

LENZ Therapeutics Price Target Announced at $38.00/Share by HC Wainwright & Co.

Dow JonesAug 12 07:27 ET

LENZ Therapeutics Analyst Ratings

BenzingaAug 12 07:18 ET

TransCode Therapeutics Analyst Ratings

BenzingaMay 29 12:34 ET

Analysts Are Bullish on These Healthcare Stocks: Assertio Therapeutics (ASRT), SurModics (SRDX)

TipRanksMay 29 09:03 ET

Truist Financial Sticks to Its Buy Rating for Corcept Therapeutics (CORT)

TipRanksMay 29 07:57 ET

Buy Rating Affirmed for Cognition Therapeutics on Promising Alzheimer's Drug Candidate CT1812

TipRanksMay 29 06:21 ET

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Fortrea Holdings Inc. (FTRE) and Cellectis SA (CLLS)

TipRanksMay 29 05:55 ET

Sage Therapeutics Analyst Ratings

BenzingaMay 29 05:11 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Teleflex (TFX), Bioxcel Therapeutics (BTAI) and Prothena (PRTA)

TipRanksMay 29 00:39 ET

Strong Buy Rating for Enliven Therapeutics' ELVN-001 Amid Favorable Market Dynamics

TipRanksMay 28 22:38 ET

Analysts' Top Healthcare Picks: Biohaven Ltd. (BHVN), Sarepta Therapeutics (SRPT)

TipRanksMay 28 21:20 ET

Buy Rating Justified by Outlook Therapeutics' Advancements and Market Prospects

TipRanksMay 28 20:08 ET

Sell Rating on SAGE Therapeutics Amidst High Risk and Uncertain Pipeline Success

TipRanksMay 28 17:56 ET

PTC Therapeutics Analyst Ratings

BenzingaMay 28 11:47 ET